Bisaramil and antiarrhythmics as inhibitors of free radical generation

Pharmacological Research

Volumn 35, Issue 4, 1997, Pages 279-285

  Paróczai, Margit ^a   Röth, Elizabeth ^b   Kárpáti, Egon ^a  

^a GEDEON RICHTER LTD   (Hungary)

^b NONE

Author keywords

Bisaramil; Free radicals; Polymorph neutrophil granulocytes

Indexed keywords

ANTIARRHYTHMIC AGENT; BISARAMIL; DILTIAZEM; FREE RADICAL; MEXILETINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROPAFENONE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; DOG; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031126853     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0128     Document Type: Article

References (44)

1. Barnier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Circ Res. 58:1986;331-340.
2. Curtis MJ, Pugsley MK, Walker AJA. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Cardiovasc Res. 27:1983;703-719.
3. Dinerman J, Mehta J, Lawson D, Mehta P. Enhancement of human neutrophil function by platelets: Effects of indomethacin. Thrombosis Res. 49:1988;509-517.
4. Entman ML, Micheal L, Rossen RD, Dreyer WJ, Anderson DC, Taylor AR, Smith CW. Inflammation in the course of early myocardial ischemia. FASEB J. 5:1991;2529-2537.
5. Weisman G, Smolen J, Korchak H. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med. 303:1980;27-29.
6. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation. 80:1989;1816-1827.
7. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol. 11:1988;1309-1316.
8. Go LJ, Murray CE, Richard VJ, Weischendel GR, Jennings RB, Reimer KA. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol. 24(Heart Circ Physiol):1988;H1188-H1198.
9. Reynolds JM, McDonagh PF. Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance. Am J Physiol. 256:1989;H982-H989.
10. Sheridan FM, Dauber IM, McMurtry IF, Lesnefsky EJ, Horowitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res. 69:1991;1566-1574.
11. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation. 68 (suppl I.):1983;I.8-I.15.
12. Braunwald E, Kloner RA. Myocardial reperfusion: A double edged sword. J Clin Invest. 76:1985;1713-1719.
13. Snyderman R, Goetzl E. Molecular and cellular mechanisms of leukocyte chemotaxis. Science. 213:1981;830-832.
14. Fantone JC, Ward PA. Role of oxygen derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 107:1982;397-418.
15. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radical in ischemic myocardial injury. J Mol Cell Cardiol. 21:1989;1241-1251.
16. Enger RL, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15 minute ischemia in the dog. Circ Res. 61:1987;20-28.
17. Pallandi RT, Perry MA, Campell TJ. Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: A possible cause of reperfusion induced arrhythmias. Circ Res. 61:1987;50-54.
18. Romson J, Hook B, Rigot V, Schork A, Swanson D, Lucchesi B. The effect of ibuprofen on accumulation of Indium-111 labelled platelets and leukocytes in experimental myocardial infarction. Circulation. 66:1982;1002-1011.
19. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anaesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmac Exp Ther. 228:1984;510-522.
20. Simpson PJ, Todd RF, Mickelson JK. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation. 81:1990;226-237.
21. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork A, Lucchesi BR. Reduction in the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1983;1016-1023.
22. Paróczai M, Kárpáti E, Solti F. The effects of bisaramil on experimental arrhythmias. Pharm Res. 22:1990;463-480.
23. Paróczai M, Kárpáti M. Investigations to characterize a new antiarrhythmic drug, bisaramil. Pharm Res. 24:1991;149-162.
24. Paróczai M, Kárpáti E, Marko R, Kecskeméti V. Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations. Pharm Res. 25:1992;75-85.
25. Paróczai M, Röth E, Matos G, Temes GY, Lantos J, Kárpáti E. Effects of bisaramil on coronary-occlusion-reperfusion injury and free radical induced reactions. Pharm Res. 33:1996;327-360.
26. Guarnieri C, Melandori G, Caldarera I, Scheda M, Ligabue A, Guizzardi S, Branzi A. Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Function. 8:1990;157-169.
27. Tallarida JR, Murray RB. Manual pharmacologic calculations with computer programs. 1981;Springer Verlag New York Inc.
28. Ginks WR, Sybers PR, Covell JW, Sobel SE, Ross J. Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after coronary occlusion. J Clin Invest. 51:1972;2717-2717.
29. Reimer KA, Lower JE, Rasmussen MM, Jennings RB. The wave-front phenomenon of ischemic cell death. I. Myocardial infarct sizevs. Circulation. 56:1977;786-786.
30. Laffel GL, Braunwald E. Thrombolytic therapy. N Engl J Med. 311:1984;710-710.
31. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, Leinbach RC, Brinker JA, Ludbrook PA, Yasuda I, Bulkley BH, Robinson AK, Hutter AM, Bell WR, Sparado JJ, Khaw BA, Grosshard EB. Coronary thrombolysis with recombinant human tissue-type plasminogen activator; a prospective randomized, placebo-controlled trial. Circulation. 70:1984;1012-1012.
32. Meyer J, Merx W, Schmitz H, Erbel R, Kiesslich T, Dorr R, Lambertz H, Bethge C, Krebs W, Bardos P, Minale C, Messmer BJ, Effert S. Precutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transluminal myocardial infarction. Circulation. 66:1982;905-905.
33. Rude RE, Muller JE, Braunwald E. Efforts to limit the size of myocardial infarcts. Ann Intern Med. 95:1981;736-736.
34. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol. 7:1977;315-315.
35. Ganote CE, Kaltenbach JP. Oxygen induced enzyme release: Early events and proposed mechanism. J Mol Cell Cardiol. 11:1974;389-389.
36. Enger RL. Granulocytes and oxidative injury in myocardial ischemia and reperfusion. Fed Proc. 46:1987;2395-2396.
37. Przyklenk K, Kloner RA. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis? Basic Res Cardiol. 82:1987;146-158.
38. Lucchesi BR, Romson JL, Jolly SR. Do leukocytes influence infarct size? Therapeutic approaches to myocardial infarcat size limitation. 1984;Raven Press, New York.
39. Mitsos SE, Askew TE, Fantone JC, Kunkel SL, Abrams GD, Schork A, Lucchesi BR. Protective effects ofN. Circulation. 73:1986;1077-1086.
40. Devi P. Chemical radiation protection by alpha-mercaptopropionyl-glycine. J Nucl Med Sci. 27:1983;327-327.
41. Tosaki A, Szekeres L, Hearse DJ. Diltiazem and the reduction of reperfusion-induced arrhythmias in the rat: Protection is secondary to modification of ischemic injury and heart rate. J Mol Cell Cardiol. 19:1987;441-451.
42. Röth E. Effects of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. Bratisl Lek Listy. 3:1991;195-200.
43. Rotmensh HH, Belhassen B, Ferguson RK. Amiodarone - benefits and risks in perspective. Am Heart J. 104:1982;1117-1119.
44. Rotmensh HH, Belhassen B, Swanson B. Steady state serum amiodarone concentrations: Relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med. 101:1984;462-469.